C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/08 (2006.01) A61K 31/439 (2006.01) A61P 1/00 (2006.01) A61P 9/00 (2006.01) A61P 11/00 (2006.01)
Patent
CA 2676581
This invention relates to M3 antagonists of formula (I) wherein R2, R4, R5, R6, W, V, A, D, X, t, u and v are as defined herein; pharmaceutical compositions containing them; methods for their preparation; and their use in the treatment of diseases where enhanced M3 receptor activation is implicated.
Cette invention porte sur des antagonistes M3 de formule (I) dans laquelle R2, R4, R5, R6, W, V, A, D, X, t, u et v sont tels que définis présentement ; sur des compositions pharmaceutiques les contenant ; sur des procédés pour leur préparation ; et sur leur utilisation dans le traitement de maladies où une activation accrue du récepteur M3 est impliquée.
Avitabile Barbara Giuseppina
Finch Harry
Knight Jamie David
Nadin Alan John
Ray Nicholas Charles
Argenta Discovery Limited
Fetherstonhaugh & Co.
LandOfFree
Heterocyclic derivatives as m3 muscarinic receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic derivatives as m3 muscarinic receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic derivatives as m3 muscarinic receptors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1798543